Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 284 of 6351
-
A Two-Pronged attack on sedentary aging: less sitting, more Nrf2
Disease control Not yet recruitingExercise is the cornerstone of rehabilitation and an essential part of treatment plans for many chronic conditions; however, our understanding of why certain individuals respond positively to exercise while others do not remains incomplete. Physical inactivity and sedentary behav…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Fetal heart surgery could change life for babies with Half-Formed hearts
Disease control By invitation onlyThe purpose of this research is to investigate the best way to manage evolving hypoplastic left heart syndrome (HLHS).
Sponsor: Mauro H. Schenone • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
MRNA cancer shot shows promise in early trial
Disease control Not yet recruitingPMC2129G12 is an investigational intratumorally administered messenger RNA-lipid nanoparticle (mRNA-LNP) immunotherapy designed to enable localized, transient expression of a humanized EpCAM-targeted CD3-engaging bispecific antibody together with the immunostimulatory cytokines t…
Phase 1/2 • Sponsor: IntraAb, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Handheld ultrasound could spot hidden graft failures during bypass surgery
Disease control Not yet recruitingThis single-centre, prospective observational feasibility and safety study will enrol 190 consecutive adults undergoing elective isolated coronary artery bypass grafting (CABG) at Nanjing Drum Tower Hospital. The study aims to evaluate the feasibility and safety of intraoperative…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
AI-Powered ECG could reveal hidden heart recovery after ablation
Knowledge-focused Not yet recruitingBackground Artificial intelligence-enabled electrocardiography (AI-ECG) has emerged as a promising digital biomarker for detecting latent myocardial dysfunction and predicting cardiovascular risk. However, whether serial AI-derived risk estimates reflect myocardial recovery follo…
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
Disease control Not yet recruitingTuberculosis (TB) affects millions of people worldwide, and many individuals continue to experience long-term health problems even after completing TB treatment. One of the most important of these complications is post-tuberculosis lung disease (PTLD), which can cause persistent …
Sponsor: Jose Antonio Dominguez Benitez • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A 4-session couples therapy aims to curb violence in veteran relationships
Disease control Not yet recruitingThis study will address a pressing unmet need for effective and accessible treatment for Veteran couples with intimate partner violence (IPV). The primary objective is to adapt a brief intervention originally developed to reduce general aggression among individual Veterans with P…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a hyperactive immune system fuel PMDD? a new study investigates
Knowledge-focused Not yet recruitingScientists have found that the immune system, the body's system dedicated to fighting infections, can be in a state of "hyperactivity" (i.e., more active than you would normally expect) in some people with depression and postnatal depression, despite the lack of any actual ongoin…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Could intense workouts be safe after a rare heart attack? a trial puts HIIT to the test
Disease control By invitation onlyThe goal of this randomized clinical trial is to determine whether a supervised high-intensity interval training (HIIT) program can safely improve cardiorespiratory fitness and overall health in adults who have previously had spontaneous coronary artery dissection (SCAD), a non-a…
Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Rapid test may cut time on wrong antibiotics after lung transplant
Diagnosis Not yet recruitingPostoperative pneumonia significantly worsens the prognosis for patients undergoing lung transplantation (LT). It is therefore recommended to use antibiotic prophylaxis after LT, although the specific types of antibiotics or the duration of treatment are not specified. Internatio…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Magic mushroom therapy for depression? new trial tests psilocybin and CBT in groups
Symptom relief Not yet recruitingThis study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms a…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could stem cells help people with spinocerebellar ataxia? new trial aims to find out
Disease control Not yet recruitingThe purpose of this study is verify the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Spinocerebellar Ataxia, and in addition, explore the possible mechanisms of UC-MSC therapy in Spinocerebellar Ataxia.
Phase 2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to slow advanced cervical cancer
Disease control Not yet recruitingAdvanced cervical cancer patients treated with standard of care (SOC) chemoradiation plus glutaminase inhibition with telaglenastat (CB-839) will have increased progression-free survival (PFS) compared to historical rates for patients receiving SOC chemoradiation alone.
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Cord stem cells aim to reboot brain after stroke
Disease control PausedThis is a randomized, double-blind study. Human umbilical cord mesenchymal stem cells (hUC-MSC) will be treated on cerebral infarction patients, and evaluates their neurological function of convalescent period.
Phase 1/2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on tough leukemia
Disease control Not yet recruitingThe purpose of this clinical trial is to assess the feasibility, safety and efficacy of multi-CAR T cell therapy targeting different AML surface antigens in patients with relapsed or refractory acute myeloid leukemia (AML). Another goal of the study is to learn more about the fun…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Brain-Guided balance training: a new frontier in fall prevention?
Prevention Not yet recruitingThe goal of this clinical trial with an embedded observational phase is to evaluate whether a phenotype-guided, personalized rehabilitation program can improve fall risk and underlying neural control mechanisms in older adults aged ≥65 years, including both high and low fall-risk…
Sponsor: University of Sharjah • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn childhood cancers
Disease control Not yet recruitingPatients with refractory and/or recurrent solid tumor have poor prognosis despite complex multimodel therapy and therefore, novel approaches are urgently needed. The investigators are attempt to treat these diseases using T cells genetically modified with a 4th generation lentivi…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a nerve pain drug boost bladder pain relief?
Disease control Not yet recruitingBladder pain syndrome/interstitial cystitis (IC/BPS) brings long-term pelvic pain, frequent urination and poor sleep quality, which severely lowers patients' daily life quality. Educational and behavioral management program (EBMP) is a mainstream non-drug treatment for IC/BPS, ye…
Phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New vaccine takes on deadly brain tumors in early trial
Vaccine Not yet recruitingThis study is designed to treat patients who have been diagnosed with brain cancer, including glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG). The treatment uses immunomodulatory vaccine generated by autologous dendritic cells (DCs) pulsed with genetically modified…
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Vaccine
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Not yet recruitingThe purpose of this clinical trial is to assess the feasibility, safety and efficacy of PSMA-specific CAR-T cell therapy in patients with PSMA positive tumor. Another goal of the study is to learn more about the function of the PSMA CAR-T cells and their persistency in the patien…
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC